Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HGEN Humanigen Inc

0.00 (0.00%)
Feb 26 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.0356
Ask Price 0.0358
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Humanigen Inc HGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0361 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.0361 0.0361
Trades Volume Avg Volume 52 Week Range
0 0 - 0.0358 - 0.207
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0361 USD

Humanigen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.30M - - - -6.08
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Humanigen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No HGEN Message Board. Create One! See More Posts on HGEN Message Board See More Message Board Posts

Historical HGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.15230.2070.03580.11001312,695,288-0.1162-76.30%
3 Years19.0029.200.03583.743,208,878-18.96-99.81%
5 Years10.8529.200.03584.262,846,995-10.81-99.67%

Humanigen Description

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.

Your Recent History

Delayed Upgrade Clock